APA

Oran B., Giralt S., Couriel D., Hosing C., Shpall E. J., de Meis E., Khouri I. F., Qazilbash M., Anderlini P., Kebriaei P., Popat U., Carrasco-Yalan A., Champlin R. E. & de Lima M. (20071227). Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation. : Leukemia.

Chicago

Oran B, Giralt S, Couriel D, Hosing C, Shpall E J, de Meis E, Khouri I F, Qazilbash M, Anderlini P, Kebriaei P, Popat U, Carrasco-Yalan A, Champlin R E and de Lima M. 20071227. Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation. : Leukemia.

Harvard

Oran B., Giralt S., Couriel D., Hosing C., Shpall E. J., de Meis E., Khouri I. F., Qazilbash M., Anderlini P., Kebriaei P., Popat U., Carrasco-Yalan A., Champlin R. E. and de Lima M. (20071227). Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation. : Leukemia.

MLA

Oran B, Giralt S, Couriel D, Hosing C, Shpall E J, de Meis E, Khouri I F, Qazilbash M, Anderlini P, Kebriaei P, Popat U, Carrasco-Yalan A, Champlin R E and de Lima M. Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation. : Leukemia. 20071227.